BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 134480)

  • 1. [Study of the fibrinogen splitting products in the blood plasma in hyperfibrinolysis].
    Veremienko KN; Varetskaia TV; Kizim AI; Gerasimenko NG
    Ukr Biokhim Zh; 1976; 48(3):337-42. PubMed ID: 134480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antiplasmin and its effect on the process of fibrinolysis in experiments].
    Kudriashov BA; Pastorova VE
    Biull Eksp Biol Med; 1966 Feb; 61(2):40-2. PubMed ID: 4235805
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the participation of Hageman factor in fibrinolysis.
    McDonagh RP; Ferguson JH
    Thromb Diath Haemorrh; 1970 Oct; 24(1):1-9. PubMed ID: 4249468
    [No Abstract]   [Full Text] [Related]  

  • 4. The thrombolytic activity of streptokinase in the rabbit.
    English PD; Smith RA; Dupe RJ; Green J; Hibbs MJ
    Thromb Haemost; 1981 Aug; 46(2):535-7. PubMed ID: 7302893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative activities of amino acid and polypeptide inhibitors on natural and synthetic substrates.
    Skoza L; Tse AO; Semar M; Johnson AJ
    Ann N Y Acad Sci; 1968 Jun; 146(2):659-72. PubMed ID: 4239440
    [No Abstract]   [Full Text] [Related]  

  • 6. Differential inhibition with antifibrinolytic agents of staphylokinase and streptokinase induced clot lysis.
    Lijnen HR; Stassen JM; Collen D
    Thromb Haemost; 1995 May; 73(5):845-9. PubMed ID: 7482414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of coagulation and fibrinolysis by aromatic amidino compounds. An in vitro and in vivo study.
    Geratz JD
    Thromb Diath Haemorrh; 1971 Jun; 25(3):391-404. PubMed ID: 5314899
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemical control of hyperfibrinolytic states by synthetic inhibitors of fibrinolytic enzymes.
    Markwardt F; Klöcking HP
    Biomed Biochim Acta; 1983; 42(6):725-30. PubMed ID: 6605748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [On the difference between serum and euglobulin in determination of fibrinolytic activities by streptokinase-activated method with special reference to the relationship with antiplasmin agents].
    Miyatani K; Fukui I
    Rinsho Byori; 1971 Mar; 19(3):223-6. PubMed ID: 4252723
    [No Abstract]   [Full Text] [Related]  

  • 10. [Animal experimental studies on fibrinolysis with streptokinase].
    Hauptmann J; Klöcking HP
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):915-22. PubMed ID: 94886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential degradation of soluble fibrin monomers in streptokinase-activated plasma.
    Konttinen YP; Lalla ML; Turunen O
    Thromb Diath Haemorrh; 1973 Nov; 30(2):403-13. PubMed ID: 4543990
    [No Abstract]   [Full Text] [Related]  

  • 12. [Proof of the antifibrinolytic action of the protease inhibitor Contrykal in vivo].
    Klöcking HP
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):136-41. PubMed ID: 4174651
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the mechanism of action of synthetic antifibrinolytics. A comparison with the action of derivatives of benzamidine on the fibrinolytic process.
    Landmann H
    Thromb Diath Haemorrh; 1973 May; 29(2):253-75. PubMed ID: 4271586
    [No Abstract]   [Full Text] [Related]  

  • 14. [The behavior of plasmatic fibrinogenolytic activity after activation with streptokinase and urokinase in presence of epsilon amino-caproic acid and of the parotid inhibitor of trypsin].
    Ferrauto A; Cristaldi R; Terranova R; Giuffrida G
    Boll Soc Ital Biol Sper; 1965 Dec; 41(24):1486-7. PubMed ID: 5298373
    [No Abstract]   [Full Text] [Related]  

  • 15. [Inhibitor of fibrinolysis from pancreas pantrypin].
    Lakin KM; Efimov VS; Polonskaia LB
    Farmakol Toksikol; 1969; 32(6):712-5. PubMed ID: 5381603
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of products obtained by enzymatic splitting of bacterial proteins on the blood fibrinolytic system of the dog].
    Tomuş L; Suciu A; Rusu M; Cordoş D
    Fiziol Norm Patol; 1971; 17(1):11-20. PubMed ID: 5554045
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study of the bleeding mechanism during fibrinolysis induced by streptokinase in the rabbit (author's transl)].
    Bara L; Samama M; Bilski-Pasquier G; Bloch MF; Rochas S
    Pathol Biol (Paris); 1977 Dec; 25 Suppl():48-54. PubMed ID: 353658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrin deposition in the ribbit kidney produced by protease inhibitors.
    Beller FK; Mitchell PS; Gorstein F
    Thromb Diath Haemorrh; 1967 May; 17(3-4):427-39. PubMed ID: 5301528
    [No Abstract]   [Full Text] [Related]  

  • 19. The evaluation of plasmin and streptokinase activator complexes in a new rabbit model of venous thrombosis.
    Dupe RJ; English PD; Smith RA; Green J
    Thromb Haemost; 1981 Aug; 46(2):528-34. PubMed ID: 6458112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-aminomethylbicyclo[2.2.2]-octane-1-carboxylic acid a new potent antifibrinolytic agent. Its evaluation by in vitro assay procedures.
    Baumgarten W; Priester LI; Stiller DW; Duncan AE; Ciminera JL; Loeffler LJ
    Thromb Diath Haemorrh; 1969 Nov; 22(2):263-72. PubMed ID: 5380948
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.